A detailed history of Krensavage Asset Management, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Krensavage Asset Management, LLC holds 109,076 shares of JAZZ stock, worth $12.3 Million. This represents 5.35% of its overall portfolio holdings.

Number of Shares
109,076
Previous 101,151 7.83%
Holding current value
$12.3 Million
Previous $12.2 Million 4.42%
% of portfolio
5.35%
Previous 5.4%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $823,724 - $942,916
7,925 Added 7.83%
109,076 $11.6 Million
Q1 2024

May 15, 2024

BUY
$115.19 - $132.77 $132,583 - $152,818
1,151 Added 1.15%
101,151 $12.2 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $11.4 Million - $13.6 Million
100,000 New
100,000 $12.3 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.1B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Krensavage Asset Management, LLC Portfolio

Follow Krensavage Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krensavage Asset Management, LLC with notifications on news.